Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.CMS, an Elekta company, has received the FDA 510(k) clearance for its new Atlas-based autosegmentation product. This clearance allows CMS to immediately begin distributing Atlas-based autosegmentation for clinical use in the US.
Subscribe to our email newsletter
According to the company, the Atlas-based autosegmentation (ABAS) is a software application that produces an estimate of the anatomy boundary contours needed to create a radiation treatment plan. It also reduces the amount of time spent creating and editing patient contours.
Image segmentation, or contouring, is a time consuming component of the treatment planning process, and ABAS is said to help save clinicians time by providing a good starting point from which minimal editing is required.
ABAS also provides structure specific refinement algorithms for head and neck treatments, as well as prostate treatments, in addition to a general algorithm that allows it to be used with other treatment sites.